阿卡波糖对糖耐量低减患者的心血管疾病的预防  

The preventive effect of acarbose with imapired glucose tolerance population of cardiovascular disease

作　　者：彭庆奎[1] 

机构地区：[1]山东省枣庄市立医院心内一科,277100

出　　处：《中国实用医药》2008年第13期51-52,共2页China Practical Medicine

摘　　要：目的评价阿卡波糖对糖耐量低减(IGT)患者的心血管疾病的预防作用。方法选择168例行口服葡萄糖耐量试验(OGTT)诊断为IGT的患者,随机分为两组,治疗组给予阿卡波糖,观察2年心血管事件的发生率。结果治疗组冠心病的发病率为9.30%,对照组冠心病的发病率为21.95%,两组比较,P<0.05差异有统计学意义。结论阿卡波糖对IGT患者能够显著降低心血管事件的发生。Objective To investigate the preventive effect of acarbose with impaired glucose tolerance （IGT） population of developing coronary heart disease. Methods 168 patients with impaired glucose tolerance were randomly divided into control group and acarbose treatment group. All were observed carefully for two years to conclude the attack rate. Results The prevalence of coronary heart disease was 9, 30% in acarhose group, and was 21.95% in control group, （P 〈 0.05）. Conclusion The results showed that the attack rate from coronary heart disease in acarbose treatment group were less than those in the control group.

关 键 词：糖耐量低减 冠心病 阿卡波糖 发病率 

分 类 号：R587.1[医药卫生—内分泌]